about
NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension.Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension.High-mobility group box-1 induces vascular remodelling processes via c-Jun activationCompartment-specific expression of collagens and their processing enzymes in intrapulmonary arteries of IPAH patientsKi67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.Increased S100A4 expression in the vasculature of human COPD lungs and murine model of smoke-induced emphysema.Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosisPrognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age.Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesotheliomaLung cancer in never smokers.Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.The prognostic significance of β-catenin, cyclin D1 and PIN1 in minor salivary gland carcinoma: β-catenin predicts overall survival.Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy.Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors.Extracorporeal membrane oxygenation support for complex tracheo-bronchial procedures†.Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysis.CD133+ cells in pulmonary arterial hypertension.Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition.Expression of β-catenin and cyclin D1 in Merkel cell carcinomas of the head and neck.Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.Functional and molecular factors associated with TAPSE in hypoxic pulmonary hypertension.Lung transplantation in patients with incidental early stage lung cancer-institutional experience of a high volume center.Endothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent.Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapy.A rare indication for video-assisted thoracoscopic surgery: headscarf needle aspiration.Elevated inflammatory parameters and inflammation scores are associated with poor prognosis in patients undergoing pulmonary metastasectomy for colorectal cancer.Meprinβ, a novel mediator of vascular remodelling underlying pulmonary hypertensionPrimary lung transplantation after bridge with extracorporeal membrane oxygenation: a plea for a shift in our paradigms for indicationsChondroid hamartoma of the lung presenting as cavernCorrelation of β-catenin, but not PIN1 and cyclin D1, overexpression with disease-free and overall survival in patients with cancer of the parotid glandLobar lung transplantation--is it comparable with standard lung transplantation?Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients
P50
Q34025109-D8887276-F477-4A6A-8FCB-778DE2242D76Q35185482-A7B3D5B8-FE6F-4C25-A1F3-83BCFF838545Q35571972-030A752C-D2F0-4CCA-BEFF-B524F27EC7F8Q35595010-E6202DEC-5395-4BC0-90A2-65927B7678ABQ35678741-312E79E8-4500-4739-BE90-32871E291D96Q35813870-046E2E6E-8F15-477E-BDD0-0B8C2BCC6B6AQ36107360-B411B939-2E69-4A87-91AF-468E65842746Q36713512-3148C31C-B778-4522-88DD-A1AD4E2E707DQ37594406-BC65B11A-081B-473E-83A9-FACA444E7D15Q37944937-E615B458-E1E6-4704-950A-4EC39F89F4ADQ38870822-DFFACDEF-2648-44A1-A9B6-00B5B93D6A04Q38959812-2DDE4B03-BA3D-4D4C-BD31-4997E5923878Q41173300-7C7DE150-0A3D-4B5E-B8BD-052419F5EE70Q42748171-764B9E26-4855-4D4B-A23A-BD7EE68CA92EQ43815149-9469F0A5-0953-4584-A2B6-3F4BE3897939Q44034680-0E0AE31C-7FC1-40BC-8ADC-690310A007E7Q47429840-69197085-1E4C-4C66-A87B-AD3DD3F19609Q47438549-A14E31D2-C1E6-484A-8494-7FD5E75183FFQ47449827-3ABD0CB1-E715-487D-AA4B-A4748C09B3FEQ47823651-94763541-CDBE-4D1A-A370-171C94F0E3F1Q51509080-2956E882-FE1A-4FDE-B51B-F6379E5411BDQ51530668-DE57D205-034F-4B23-A1B4-0AB120551818Q52867661-894670D4-EEBF-4FF7-A932-32FB2D0C30CDQ53035336-6B7D6A11-BF52-4148-9888-ACC53AB7580EQ53055406-9A44B6C7-A28E-41D0-8C97-1DC6870CD4F0Q53113661-551294AA-7BF0-4930-AD17-552F57788D43Q53395467-80024F81-7A4F-455F-81A5-475095C36E34Q61766953-789FDE79-0E85-448F-B632-30A1E87D2BA3Q83638780-BF823CCA-B08F-4A8C-B73A-DACA99E75950Q86594723-37230B7D-94B9-4C99-B3FC-F030FEAE9335Q87240988-48D9CAB4-7A6B-441B-AAA0-90EBDC057058Q87839188-31093656-DE83-4569-A108-57CEF1C7A35DQ88164262-7F7A670D-6EDB-40FA-AFE5-5C9EEC4B1217
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Bahil Ghanim
@ast
Bahil Ghanim
@en
Bahil Ghanim
@es
Bahil Ghanim
@nl
Bahil Ghanim
@sl
type
label
Bahil Ghanim
@ast
Bahil Ghanim
@en
Bahil Ghanim
@es
Bahil Ghanim
@nl
Bahil Ghanim
@sl
prefLabel
Bahil Ghanim
@ast
Bahil Ghanim
@en
Bahil Ghanim
@es
Bahil Ghanim
@nl
Bahil Ghanim
@sl
P106
P1153
52163741300
P31
P496
0000-0002-6563-5643